Results 91 to 100 of about 1,023,256 (260)
Mucosal immunity to severe acute respiratory syndrome coronavirus 2 infection
Current Opinion in Infectious Diseases, 2021 Purpose of review Despite its crucial role in protection against viral infections, mucosal immunity has been largely understudied in the context of coronavirus disease 2019 (COVID-19). This review outlines the current evidence about the role of mucosal immune responses in the clearance of severe acute respiratory syndrome ...
Fröberg, J. +2 more
openaire +5 more sources
Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019:A Randomized, Controlled Trial [PDF]
, 2022 BACKGROUND: The aim of this randomized, controlled trial is to determine whether antisevere acute respiratory syndrome coronavirus 2 hyperimmune globulin (COVIG) protects against severe coronavirus disease 2019 (COVID-19) in severely immunocompromised ...
Bogers, Susanne +12 more
core +1 more source
Early Introduction of Severe Acute Respiratory Syndrome Coronavirus 2 into Europe [PDF]
Emerging Infectious Diseases, 2020 Early infections with severe acute respiratory syndrome coronavirus 2 in Europe were detected in travelers from Wuhan, China, in January 2020. In 1 tour group, 5 of 30 members were ill; 3 cases were laboratory confirmed. In addition, a healthcare worker was infected. This event documents early importation and subsequent spread of the virus in Europe.
Alexis Ardoin +12 more
openaire +4 more sources
Urticaria in an infant with SARS-CoV-2 positivity [PDF]
, 2020 Last months have been marked by the global spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), responsible for the coronavirus disease 19 (COVID-19 ...
Balduzzi V +10 more
core +1 more source
COVID-19 Treatment in Medan, Indonesia: A Case Report [PDF]
, 2021 In the past decades, two known zoonotic coronaviruses, SARS-CoV and MERS-CoV, have been reported to damage the respiratory tract and cause severe outbreaks.
Fadinie, Wulan
core +2 more sources
Clinical characteristics of severe acute respiratory syndrome coronavirus 2 reactivation [PDF]
Journal of Infection, 2020 Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. However, limited data was available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reactivation.
Ye, Guangming +7 more
openaire +3 more sources
Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past [PDF]
, 2020 © 2020 Elsevier B.V. Coronavirus disease 2019 (COVID-19) or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus strain disease, has recently emerged in China and rapidly spread worldwide.
Gianni, P., Giannis, D., Ziogas, I. A.
core +2 more sources
Fungal Infections Complicating COVID-19 [PDF]
, 2022 Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread globally to pandemic proportions.
core +1 more source
Journal of Medical Case Reports, 2021 Background The topic of natural immunity related to severe acute respiratory syndrome coronavirus 2 remains controversial. Although evidence suggests postinfection immunity can be achieved, there have been reported cases of reinfection with similar or ...
Nimrah Bader +2 more
doaj +1 more source
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021 Coronavirus disease 2019 (COVID‐19) is an infectious disease caused by severe acute respiratory syndrome coronavirus‐2, which has posed a significant threat to global health.
Luis Ortega‐Paz +3 more
doaj +1 more source